Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Drug pricing

NHS denied £2m of savings after hydrocortisone suppliers enter anticompetitive agreements, finds CMA

Auden Mckenzie and Waymade have been provisionally found to have broken competition law, the UK’s Competition and Markets Authority has found.

The NHS was denied potential savings on hydrocortisone tablets after two suppliers entered into anticompetitive agreements, the Competition and Markets Authority (CMA) has provisionally found.

From July 2011 to April 2015, Auden Mckenzie remained the sole supplier of 20mg hydrocortisone tablets, despite Waymade, another supplier, being ready to enter the market in May 2011 with the same tablets.

Instead, the CMA found that Waymade froze its stock and struck a deal with Auden Mckenzie to receive monthly payments in return for delaying its entry into the market.

The CMA found that between 2011 and 2015 the price of 20mg hydrocortisone tablets increased from around £46 to £90 for a pack of 30 tablets, increasing the annual costs incurred by the NHS for the medicine from £1.7m to £3.7m.

According to the CMA’s provisional findings, Waymade also obtained a licence to sell 10mg hydrocortisone tablets in September 2012 and, in exchange for Waymade not entering the market, Auden Mckenzie allegedly lowered the price it charged Waymade from the market rate of around £32 per pack to £1.

Michael Grenfell, the CMA’s executive director for enforcement, said: “The CMA has today provisionally found that Auden Mckenzie and Waymade broke competition law through Auden Mckenzie paying its rival to stay out of the market.

“Hydrocortisone is a life-saving drug for those [living] with Addison’s Disease in the UK. The NHS should not be denied the opportunity of benefitting from an increased choice of suppliers and potential savings on what it spends on this essential drug.”

Vijay Patel, the director of Waymade and a pharmacist, was awarded an OBE in the New Year’s Honours list for his services to business and philanthropy.

Following this provisional finding, the companies will now be able to state their case to the CMA before it reaches a final decision.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206236

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmaceutical Statistics

    Pharmaceutical Statistics

    This book on basic statistics has been specifically written for pharmacy students.

    £33.00Buy now
  • Pharmacy and Medicines Law in Ireland

    Pharmacy and Medicines Law in Ireland

    This practical textbook covers all aspects of current pharmacy and medicines law in Ireland.

    £40.00Buy now
  • FASTtrack: Law and Ethics in Pharmacy Practice

    FASTtrack: Law and Ethics in Pharmacy Practice

    FASTtrack: Law and Ethics in Pharmacy Practice covers key legislation affecting pharmacy and the pharmacist practitioner.

    £28.00Buy now
  • Dale and Appelbe's Pharmacy and Medicines Law

    Dale and Appelbe's Pharmacy and Medicines Law

    This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.

    £57.00Buy now
  • Pharmacy Registration Assessment Questions

    Pharmacy Registration Assessment Questions

    Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.

    £33.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.